Prolonged cell cycle arrest in irradiated human diploid skin fibroblasts: The role of nutrient deprivation

Radiation Research

Volumn 153, Issue 2, 2000, Pages 131-143

  DeSimone, John N ^a   Dolezalova, Hana ^a   Redpath, J Leslie ^b   Stanbridge, Eric J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL SURVIVAL; COLONY FORMATION; CONTACT INHIBITION; CONTROLLED STUDY; CULTURE MEDIUM; DIPLOIDY; DNA DAMAGE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IONIZING RADIATION; IRRADIATION; NUTRIENT; PRIORITY JOURNAL; PROTEIN INDUCTION; RADIATION DOSE; SKIN FIBROBLAST; WESTERN BLOTTING;

EID: 0033967416     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0131:PCCAII]2.0.CO;2     Document Type: Article

References (47)

1. J. F. Ward, DNA damage produced by ionizing radiation in mammalian cells: Identities, mechanisms of formation, and repairability. Prog. Nucleic Acid Res. Mol. Biol. 35, 95-125 (1988).
2. C. Y. Li, D. W. Yandell and J. B. Little, Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in vitro. Somat. Cell. Mol. Genet. 8, 77-87 (1992).
3. B. A. Marder and W. F. Morgan, Delayed chromosomal instability induced by DNA damage. Mol. Cell Biol. 13, 6667-6677 (1993).
4. P. Hahn, B. Nevaldine and W. F. Morgan, X-ray induction of methotrexate resistance due to dhfr gene amplification. Somat. Cell. Mol. Genet. 16, 413-423 (1990).
5. W. F. Morgan, J. P. Day, M. I. Kaplan, E. M. McGhee and C. L. Limoli, Genomic instability induced by ionizing radiation. Radiat. Res. 146, 247-258 (1996).
6. K. C. Cheng and L. A. Loeb, Genomic instability and tumor progression: Mechanistic considerations. Adv. Cancer Res. 60, 121-156 (1993).
7. E. J. Bernhard, A. Maity, R. J. Muschel and W. G. McKenna, Effects of ionizing radiation on cell cycle progression. Radiat. Environ. Biophys. 34, 79-83 (1995).
8. C. J. Leonard, C. E. Canman and M. B. Kastan, The role of p53 in cell cycle control and apoptosis. In Important Advances in Oncology (V. T. DeVita, S. Hellman and S. A. Rosenberg, Eds.), pp. 33-42. J. B. Lippincott, Philadelphia, 1995.
9. T. Enoch and C. Norbury, Cellular responses to DNA damage: Cell cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20, 426-430 (1995).
10. L. S. Cox and D. P. Lane, Tumor suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage. BioEssays 17, 501-508 (1995).
11. P. C. Nowell, The clonal evolution of tumor cell populations. Science 194, 23-28 (1976).
12. L. Loeb, Microsatellite instability: Marker of a mutator phenotype in cancer. Cancer Res. 54, 5059-5063 (1994).
13. W. El-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
14. T. Hunter, Braking the cycle. Cell 75, 839-841 (1993). [News]
15. Y. Xiong, G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi and D. Beach, p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704 (1993).
16. 2/M and the G, cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8493-8497 (1995).
17. M. B. Kastan, O. Onyekwere, D. Sidransky. B. Vogelstein and R. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
18. S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh and M. B. Kastan, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495 (1992).
19. 2/M-phase transition. Mol. Cell. Biol. 18, 546-557 (1998).
20. W. G. McKenna, G. Iliakis, M. C. Weiss, E. J. Bernhard and R. J. Muschel, Increased G, delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat. Res. 125, 283-287 (1991).
21. D. P. Lane, p53, guardian of the genome. Nature 358, 15-16 (1992). [News]
22. R. A. Weinberg. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
23. A. Di Leonardo, S. P. Linke, K. Clarkin and G. M. Wahl, DNA damage triggers a prolonged p53-dependent G, arrest and long-term induction of Cipl in normal human fibroblasts. Genes Dev. 8, 2540-2551 (1994).
24. S. P. Linke, K. C. Clarkin and G. M. Wahl, p53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation. Cancer Res. 57, 1171-1179 (1997).
25. J. B. Little and H. Nagasawa, Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal ataxia-telangiectasia fibroblasts. Radiat. Res. 101, 81-93 (1985).
26. C. F. Arlett, M. H. L. Green, A. Priestley, S. A. Harcourt and L. V. Mayne, Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int. J. Radiat. Biol. 54, 911-928 (1988).
27. H. Nagasawa, J. B. Little, N. M. Tsang, E. Saunders, J. Tesmer and G. F. Strniste, Effect of dose rate on the survival of irradiated human skin fibroblasts. Radiat. Res. 132, 375-379 (1992).
28. 2/M delay and cellular radiosensitivity. Int. J. Radiat. Biol. 66, 373-379 (1994).
29. N-M. Tsang, H. Nagasawa, C. Li and J. B. Little, Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene 10, 2403-2408 (1995).
30. 1arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem. 270, 11033-11036 (1995).
31. A. Gualberto, K. Aldape, K. Kozakiewicz and T. D. Tlsty, An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl. Acad. Sci. USA 95, 5166-5171 (1998).
32. S. Coats, W. M. Flanagan, J. Nourse and J. M. Roberts, Requirement of p27Kipl for restriction point control of the fibroblast cell cycle. Science 272, 877-880 (1996).
33. L. D. Attardi, S. W. Lowe, J. Brugarolas and T. Jacks, Transcriptional activation by p53 but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15, 3693-3701 (1996).
34. S. Rowan, R. L. Ludwig, Y. Haupt, S. Bates, X. Lu, M. Oren and K. H. Vousden, Specific loss of apoptotic but not cell cycle arrest function in a human tumor derived p53 mutant. EMBO J. 15, 827-838 (1996).
35. 1 arrest and induces apoptosis in human cancer cells. Oncogene 15, 1903-1909 (1997).
36. Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14, 929-935 (1997).
37. K. Polyak, T. Waldman, T-C. He, K. W. Kinzler and B. Vogelstein, Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945-1952 (1996).
38. 2 phase: Regulation of the γ-irradiation-induced delay and DNA repair. Oncogene 15, 2597-2607 (1997).
39. N. S. Pellegata, R. J. Antoniono, J. L. Redpath and E. J. Stanbridge, DNA damage and p53-mediated cell cycle arrest: A reevaluation. Proc. Natl. Acad. Sci. USA 93, 15209-15214 (1996).
40. D. Wynford-Thomas, p53: Guardian of cellular senescence. J. Pathol. 180, 118-121 (1996).
41. A. Di Leonardo, S. P. Linke, Y. Yin and G. M. Wahl, Cell cycle regulation of gene amplification. Cold Spring Harbor Symp. Quant. Biol. 58, 655-667 (1993).
42. 1 arrest by cell-substratum interactions. Cancer Res. 57, 1151-1156 (1997).
43. N. J. Bentley and A. M. Carr, DNA-structure-dependent checkpoints in model systems. Biol. Chem. 378, 1267-1274 (1997).
44. G. Iliakis, Cell cycle regulation in irradiated and nonirradiated cells. Semin. Oncol. 24, 602-615 (1997).
45. 2 phase checkpoints. Cancer Surveys 29, 151-182 (1997).
46. 1 arrest checkpoint in response to DNA damage. Mol. Cell. Biol. 18, 378-387 (1998).
47. K. Polyak, J-Y. Kato, M. J. Solomon, S. J. Sherr, J. Massague, J. M. Roberts and A. Koff, A. p27Kipl, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22 (1994).